---

SPECIALITY PRACTICE RESIDENCY IN PHARMACOTHERAPY
University Hospital and South Texas Veterans Health Care System
in conjunction with the University of Texas, College of Pharmacy

LOCATION:
San Antonio, Texas

LENGTH OF RESIDENCY:
1 year or 2 years (in conjunction with M.S. in Pharmacy)

START DATE:
July 1

REQUIREMENTS:
Pharm.D. degree from ACPE-accredited institution.
Texas licensure by September 1.
Completion of a Pharmacy Practice Residency or equivalent experience.

STIPEND:
Competitive salary plus an attractive benefits package including two weeks vacation, professional travel time and partial funding for attending a national professional or scientific meeting and premium-sharing for health insurance through the University plan.

CONTACT:
Robert L. Talbert, Pharm.D.
Professor
University of Texas Health Science Center at San Antonio
Pharmacotherapy Education & Research Center
7703 Floyd Curl Drive - MSC 6220
San Antonio, TX 78229-3900
(210) 567-8318
(210) 567-8328 - fax
talbert@uthscsa.edu

Program Description The Specialty Practice Residency in Pharmacotherapy will be conducted principally at University Hospital and the primary care experiences are at the VA Hospital clinics. Rotations emphasizing direct patient care responsibility are one month in length and the core experience provided over 12 months includes Adult Internal Medicine (3 months), Oncology (1 month), Neurology (1 month), HIV Service (1 month), Critical Care (1 month) and electives (4 months) as well as continuous primary care clinic involvement for one one-half day per week for one year. Elective rotations include but are not limited to Endocrinology, Cardiology, Dermatology, Rheumatology, Geriatrics, Hospice, HIV, Infectious Disease, and Pharmacoeconomics.

Residents meet on a weekly basis with the preceptors. During these conjoint sessions, cased-based, problem-solving utilizing the evidence-based medicine approach is emphasized for each of the topics described in the Pharmacotherapy Learning Objectives (6). Nationally recognized clinical practice guidelines for disease management are used as the basis for discussion of individual cases presented. Bimonthly journal club presentations of current literature are designed to enhance Domain II skills in Pharmacotherapy Practice. Residents are required to design one research protocol and IRB submission and are encouraged to participate in ongoing research projects. Residents participate in didactic courses and serves as preceptors for clinical clerkships of baccalaureate and Pharm.D. students. A presentation to all faculty and residents, Pharmacotherapy Conference, is also required. Residents may also be asked to participate in service for the Division through committees and other activities.

Principal Program Preceptors [Residents chose a primary preceptor from this list for each residency program]
Robert L. Talbert, Pharm. D., Adult Medicine, University Hospital
David S. Burgess, Pharm. D., Infectious Disease, University Hospital
Henry I. Bussey, Pharm. D., Ambulatory Care, University Health System and Private Clinics
Jodi Grabinski, Pharm. D., Oncology, University of Texas at Austin
Rebecca Greene, Pharm.D., Oncology, VA Hospital
William Linn, Pharm. D., Primary and Ambulatory Care, VA Hospital
Elizabeth Perz, Pharm. D., Adult Medicine and Ambulatory Care, VA Hospital
Susan Rogers, Pharm. D., Neurology, VA Hospital
Laurajo Ryan, Pharm. D., University Hospital
Nathan Wiederhold, Pharm. D., Infectious Disease, University of Texas at Austin

References

1. Miller WA, Dukes GE, Gal P, Porter WC, Rush DR, Schneider P, Talbert RL, Vlasses PH, Zarowitz BJ. Recognition of Pharmacotherapy as a Pharmacy Practice Specialty: An Historical Account and View of the Future. Pharmacotherapy 1992;12:475-476.
2. Dukes GE, Gal P, Miller WA, Porter WC, Rush DR, Schneider P, Talbert RL, Vlasses PH, Zarowitz BJ. Pharmacotherapy Specialty Certification Process. I. Role Delineation Study. Pharmacotherapy 1992;12:477-483.
3. Talbert RL, Gal P, Dukes GE, Miller WA, Porter, WC, Rush DR, Schneider P, Vlasses PH, Zarowitz BJ. Pharmacotherapy Specialty Certification Examination. II. Blueprint to Examination. Pharmacotherapy 1992;12:484-490.
4. Vlasses PH, Rush DR, Dukes GE, Gal P, Miller WA, Porter WC, Schneider P, Talbert RL, Zarowitz BJ. Pharmacotherapy Specialty Certification Examination. III. Results of Initial Administration. Pharmacotherapy 1992;12:491-494.
5. Zarowitz BJ, Vlasses PH, Dukes GE, Gal P, Miller WA, Porter WC, Rush DR, Schneider P, Talbert RL. Pharmacotherapy Specialty Certification Examination. IV. 1992 Results and Process Modifications, Including Recertification. Pharmacotherapy 1993;13:262-266.
6. ASHP supplemental standard and learning objectives for residency training in Pharmacotherapy practice. Am J Health-Sys Pharm. 1996:53:59-66.

The University of Texas at Austin and its affiliated institutions are an Equal Opportunity/Affirmative Action Employer.  Qualified women and minorities are encouraged to apply.  Security sensitive; conviction verification conducted on applicant selected.